| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:731665 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ANXA3 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:731665 | 6480464 | Ethinyl Estradiol affects the expression of ANXA3 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:731665 | 6480464 | Ethinyl Estradiol results in increased expression of ANXA3 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:2119 | 6480464 | Ethinyl Estradiol results in increased expression of ANXA3 mRNA | CTD | PMID:17557909 |
| 17beta-estradiol | increases expression | ISO | RGD:731665 | 6480464 | Estradiol results in increased expression of ANXA3 mRNA | CTD | PMID:15289156 |
| 2,2,2-tetramine | multiple interactions | ISO | RGD:2119 | 6480464 | Trientine inhibits the reaction [Streptozocin results in increased expression of ANXA3 protein] | CTD | PMID:21136691 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731665 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ANXA3 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:731665 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ANXA3 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731665 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ANXA3 mRNA | CTD | PMID:15667827 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:2119 | 6480464 | 2,4-dinitrotoluene affects the expression of ANXA3 mRNA | CTD | PMID:21346803 |
| 2-acetamidofluorene | increases expression | ISO | RGD:731665 | 6480464 | 2-Acetylaminofluorene results in increased expression of ANXA3 mRNA | CTD | PMID:17317680 |
| 2-acetamidofluorene | multiple interactions | ISO | RGD:731665 | 6480464 | TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of ANXA3 mRNA] | CTD | PMID:17317680 |
| 2-acetamidofluorene | multiple interactions | ISO | RGD:2119 | 6480464 | [Carbon Tetrachloride co-treated with 2-Acetylaminofluorene] results in increased expression of ANXA3 mRNA | CTD | PMID:18071240 |
| 2-methoxyethanol | increases expression | ISO | RGD:2119 | 6480464 | methyl cellosolve results in increased expression of ANXA3 mRNA | CTD | PMID:21061450 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:731665 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ANXA3 mRNA | CTD | PMID:16054899 |
| 3H-1,2-dithiole-3-thione | decreases expression | ISO | RGD:2119 | 6480464 | 1,2-dithiol-3-thione results in decreased expression of ANXA3 mRNA | CTD | PMID:19162173 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of ANXA3 mRNA | CTD | PMID:17039268 |
| aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of ANXA3 protein | CTD | PMID:20106945 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ANXA3 mRNA | CTD | PMID:21934132 |
| ammonium chloride | affects expression | ISO | RGD:2119 | 6480464 | Ammonium Chloride affects the expression of ANXA3 mRNA | CTD | PMID:16483693 |
| aniline | increases nitrosation | ISO | RGD:2119 | 6480464 | aniline results in increased nitrosation of ANXA3 protein | CTD | PMID:21708182 |
| asbestos | decreases expression | EXP | | 6480464 | Asbestos results in decreased expression of ANXA3 mRNA | CTD | PMID:22398240 |
| benzene | increases expression | ISO | RGD:731665 | 6480464 | Benzene results in increased expression of ANXA3 mRNA | CTD | PMID:15120971 PMID:15122651 |
| benzene | increases expression | ISO | RGD:731665 | 6480464 | Benzene results in increased expression of ANXA3 mRNA | CTD | PMID:15122651 PMID:15120971 |
| benzo[a]pyrene | decreases expression | ISO | RGD:731665 | 6480464 | Benzo(a)pyrene results in decreased expression of ANXA3 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | increases expression | ISO | RGD:731665 | 6480464 | Benzo(a)pyrene results in increased expression of ANXA3 mRNA | CTD | PMID:22228805 PMID:22610609 |
| benzo[a]pyrene | increases expression | ISO | RGD:731665 | 6480464 | Benzo(a)pyrene results in increased expression of ANXA3 mRNA | CTD | PMID:22228805 |
| cadmium dichloride | affects expression | ISO | RGD:2119 | 6480464 | Cadmium Chloride affects the expression of ANXA3 mRNA | CTD | PMID:22110744 |
| calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of ANXA3 mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of ANXA3 mRNA | CTD | PMID:21592394 |
| carbonyl sulfide | increases expression | ISO | RGD:2119 | 6480464 | carbonyl sulfide results in increased expression of ANXA3 mRNA | CTD | PMID:19395590 |
| choline | multiple interactions | ISO | RGD:731665 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANXA3 mRNA | CTD | PMID:20938992 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of ANXA3 mRNA | CTD | PMID:19320972 |
| copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of ANXA3 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of ANXA3 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of ANXA3 mRNA | CTD | PMID:19549813 |
| coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA3 mRNA | CTD | PMID:19167446 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of ANXA3 mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of ANXA3 mRNA | CTD | PMID:20106945 PMID:21632981 |
| desferrioxamine B | multiple interactions | EXP | | 6480464 | ferric ammonium citrate inhibits the reaction [Deferoxamine results in increased expression of ANXA3 protein] | CTD | PMID:19515424 |
| desferrioxamine B | decreases expression | EXP | | 6480464 | Deferoxamine results in decreased expression of ANXA3 protein | CTD | PMID:19515424 |
| dexamethasone | multiple interactions | ISO | RGD:731665 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ANXA3 mRNA | CTD | PMID:16054899 |
| diarsenic trioxide | decreases response to substance | EXP | | 6480464 | ANXA3 protein results in decreased susceptibility to arsenic trioxide | CTD | PMID:20707922 |
| dibutyl phthalate | increases expression | ISO | RGD:731665 | 6480464 | Dibutyl Phthalate results in increased expression of ANXA3 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:2119 | 6480464 | Dibutyl Phthalate results in increased expression of ANXA3 mRNA | CTD | PMID:21266533 |
| dichlorine | increases expression | ISO | RGD:2119 | 6480464 | Chlorine results in increased expression of ANXA3 mRNA | CTD | PMID:18636392 |
| dichlorine | multiple interactions | ISO | RGD:2119 | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of ANXA3 mRNA | CTD | PMID:18636392 |
| diethyl maleate | decreases expression | ISO | RGD:2119 | 6480464 | diethyl maleate results in decreased expression of ANXA3 mRNA | CTD | PMID:21161181 |
| diethylstilbestrol | increases expression | ISO | RGD:731665 | 6480464 | Diethylstilbestrol results in increased expression of ANXA3 mRNA | CTD | PMID:15289156 |
| ethanol | increases expression | ISO | RGD:2119 | 6480464 | Ethanol results in increased expression of ANXA3 mRNA | CTD | PMID:17920746 |
| fenofibrate | decreases expression | ISO | RGD:2119 | 6480464 | Fenofibrate results in decreased expression of ANXA3 protein | CTD | PMID:20118634 |
| ferric ammonium citrate | multiple interactions | EXP | | 6480464 | ferric ammonium citrate inhibits the reaction [Deferoxamine results in increased expression of ANXA3 protein] | CTD | PMID:19515424 |
| flurbiprofen | increases expression | ISO | RGD:731665 | 6480464 | Flurbiprofen results in increased expression of ANXA3 mRNA | CTD | PMID:16949054 |
| folic acid | multiple interactions | ISO | RGD:731665 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANXA3 mRNA | CTD | PMID:20938992 |
| genistein | increases expression | ISO | RGD:731665 | 6480464 | Genistein results in increased expression of ANXA3 mRNA | CTD | PMID:15289156 |
| genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of ANXA3 protein | CTD | PMID:20884965 |
| genistein | multiple interactions | EXP | | 6480464 | ESR2 promotes the reaction [Genistein results in decreased expression of ANXA3 protein] | CTD | PMID:20884965 |
| griseofulvin | affects expression | ISO | RGD:731665 | 6480464 | Griseofulvin affects the expression of ANXA3 mRNA | CTD | PMID:12735108 |
| ibuprofen | affects expression | EXP | | 6480464 | Ibuprofen affects the expression of ANXA3 mRNA | CTD | PMID:17070997 |
| ketamine | decreases expression | ISO | RGD:2119 | 6480464 | Ketamine results in decreased expression of ANXA3 mRNA | CTD | PMID:20080153 |
| L-methionine | multiple interactions | ISO | RGD:731665 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANXA3 mRNA | CTD | PMID:20938992 |
| lithocholic acid | increases expression | ISO | RGD:731665 | 6480464 | Lithocholic Acid results in increased expression of ANXA3 mRNA | CTD | PMID:20359477 |
| lithocholic acid | multiple interactions | ISO | RGD:731665 | 6480464 | Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in increased expression of ANXA3 mRNA] | CTD | PMID:20359477 |
| lucanthone | decreases expression | EXP | | 6480464 | Lucanthone results in decreased expression of ANXA3 mRNA | CTD | PMID:21148553 |
| methamphetamine | decreases expression | ISO | RGD:2119 | 6480464 | Methamphetamine results in decreased expression of ANXA3 protein | CTD | PMID:19826936 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:2119 | 6480464 | Diethylnitrosamine results in increased expression of ANXA3 mRNA | CTD | PMID:19638242 |
| ochratoxin A | increases expression | ISO | RGD:2119 | 6480464 | ochratoxin A results in increased expression of ANXA3 mRNA | CTD | PMID:18417182 |
| ozone | multiple interactions | ISO | RGD:2119 | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of ANXA3 mRNA | CTD | PMID:18636392 |
| paracetamol | affects expression | ISO | RGD:731665 | 6480464 | Acetaminophen affects the expression of ANXA3 mRNA | CTD | PMID:17562736 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:2119 | 6480464 | perfluorooctanoic acid results in decreased expression of ANXA3 mRNA | CTD | PMID:19162173 |
| phenobarbital | affects expression | ISO | RGD:731665 | 6480464 | Phenobarbital affects the expression of ANXA3 mRNA | CTD | PMID:19136022 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ANXA3 mRNA | CTD | PMID:16979875 |
| pirinixic acid | affects expression | ISO | RGD:731665 | 6480464 | pirinixic acid affects the expression of ANXA3 mRNA | CTD | PMID:19136022 |
| pirinixic acid | decreases expression | ISO | RGD:2119 | 6480464 | pirinixic acid results in decreased expression of ANXA3 mRNA | CTD | PMID:19162173 |
| potassium dichromate | increases expression | EXP | | 6480464 | Potassium Dichromate results in increased expression of ANXA3 protein | CTD | PMID:20332019 |
| pregnenolone 16alpha-carbonitrile | decreases expression | ISO | RGD:2119 | 6480464 | Pregnenolone Carbonitrile results in decreased expression of ANXA3 mRNA | CTD | PMID:19162173 |
| pregnenolone 16alpha-carbonitrile | multiple interactions | ISO | RGD:731665 | 6480464 | Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in increased expression of ANXA3 mRNA] | CTD | PMID:20359477 |
| quercetin | affects expression | EXP | | 6480464 | Quercetin affects the expression of ANXA3 mRNA | CTD | PMID:21632981 |
| resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of ANXA3 protein | CTD | PMID:23088850 |
| rosiglitazone | multiple interactions | ISO | RGD:731665 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ANXA3 mRNA | CTD | PMID:16054899 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of ANXA3 mRNA | CTD | PMID:17428261 |
| simvastatin | decreases expression | ISO | RGD:731665 | 6480464 | Simvastatin results in decreased expression of ANXA3 protein | CTD | PMID:14973129 |
| streptozocin | multiple interactions | ISO | RGD:2119 | 6480464 | Trientine inhibits the reaction [Streptozocin results in increased expression of ANXA3 protein] | CTD | PMID:21136691 |
| streptozocin | increases expression | ISO | RGD:2119 | 6480464 | Streptozocin results in increased expression of ANXA3 protein | CTD | PMID:21136691 |
| tamoxifen | affects expression | ISO | RGD:731665 | 6480464 | Tamoxifen affects the expression of ANXA3 mRNA | CTD | PMID:17555576 |
| tamoxifen | multiple interactions | ISO | RGD:2119 | 6480464 | [bexarotene co-treated with Tamoxifen] results in decreased expression of ANXA3 mRNA | CTD | PMID:17630414 |
| testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of ANXA3 mRNA | CTD | PMID:21592394 |
| testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of ANXA3 mRNA | CTD | PMID:21592394 |
| tetrachloromethane | decreases expression | ISO | RGD:2119 | 6480464 | Carbon Tetrachloride results in decreased expression of ANXA3 mRNA | CTD | PMID:16644059 |
| tetrachloromethane | increases expression | ISO | RGD:2119 | 6480464 | Carbon Tetrachloride results in increased expression of ANXA3 protein; more ... | CTD | PMID:18182385 |
| tetrachloromethane | multiple interactions | ISO | RGD:2119 | 6480464 | [Carbon Tetrachloride co-treated with 2-Acetylaminofluorene] results in increased expression of ANXA3 mRNA | CTD | PMID:18071240 |
| tetrachloromethane | multiple interactions | ISO | RGD:2119 | 6480464 | HGF protein affects the reaction [Carbon Tetrachloride results in increased expression of ANXA3 mRNA] | CTD | PMID:18182385 |
| trans-resveratrol | increases cleavage | EXP | | 6480464 | resveratrol results in increased cleavage of ANXA3 protein | CTD | PMID:23088850 |
| troglitazone | decreases expression | ISO | RGD:2119 | 6480464 | troglitazone results in decreased expression of ANXA3 protein | CTD | PMID:21315101 |
| urethane | multiple interactions | ISO | RGD:731665 | 6480464 | [Urethane co-treated with Freund's Adjuvant] results in decreased expression of ANXA3 mRNA | CTD | PMID:12400877 |
| urethane | decreases expression | ISO | RGD:731665 | 6480464 | Urethane results in decreased expression of ANXA3 mRNA | CTD | PMID:12400877 |
| vancomycin | decreases expression | ISO | RGD:731665 | 6480464 | Vancomycin results in decreased expression of ANXA3 mRNA | CTD | PMID:18930951 |
| zinc atom | affects expression | EXP | | 6480464 | Zinc affects the expression of ANXA3 mRNA | CTD | PMID:16979875 |
| zinc atom | multiple interactions | EXP | | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ANXA3 mRNA | CTD | PMID:16979875 |
| zinc(0) | affects expression | EXP | | 6480464 | Zinc affects the expression of ANXA3 mRNA | CTD | PMID:16979875 |
| zinc(0) | multiple interactions | EXP | | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ANXA3 mRNA | CTD | PMID:16979875 |